New insights into the pathogenesis and therapeutics of episodic ataxia type 1

Frontiers in Cellular Neuroscience
Maria Cristina D'AdamoFabio Franciolini

Abstract

Episodic ataxia type 1 (EA1) is a K(+) channelopathy characterized by a broad spectrum of symptoms. Generally, patients may experience constant myokymia and dramatic episodes of spastic contractions of the skeletal muscles of the head, arms, and legs with loss of both motor coordination and balance. During attacks additional symptoms may be reported such as vertigo, blurred vision, diplopia, nausea, headache, diaphoresis, clumsiness, stiffening of the body, dysarthric speech, and difficulty in breathing. These episodes may be precipitated by anxiety, emotional stress, fatigue, startle response or sudden postural changes. Epilepsy is overrepresented in EA1. The disease is inherited in an autosomal dominant manner, and genetic analysis of several families has led to the discovery of a number of point mutations in the voltage-dependent K(+) channel gene KCNA1 (Kv1.1), on chromosome 12p13. To date KCNA1 is the only gene known to be associated with EA1. Functional studies have shown that these mutations impair Kv1.1 channel function with variable effects on channel assembly, trafficking and biophysics. Despite the solid evidence obtained on the molecular mechanisms underlying EA1, how these cause dysfunctions within the central and ...Continue Reading

References

May 1, 1975·Journal of the Neurological Sciences·D H VanDykeM N Goldstein
Oct 1, 1990·Brain : a Journal of Neurology·E R Brunt, T W van Weerden
Jan 1, 1989·International Review of Neurobiology·C J Frederickson
Jan 1, 1986·Movement Disorders : Official Journal of the Movement Disorder Society·S T Gancher, J G Nutt
Apr 19, 1984·Nature·S Y Assaf, S H Chung
Oct 1, 1995·Journal of Neurology, Neurosurgery, and Psychiatry·W J LubbersT W van Weerden
Sep 1, 1995·Human Molecular Genetics·D L BrowneM Litt
May 26, 1998·Human Genetics·H SchefferC H Buys
Jul 31, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M C D'AdamoM Pessia
Dec 18, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·P J HandE Storey
Jan 5, 2002·The Journal of Physiology·Ruth ReaDimitri M Kullmann
Feb 13, 2003·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Timothy J Ebner, Gang Chen
Mar 4, 2003·Nature Neuroscience·Paco S HersonJames Maylie
Jun 12, 2003·Pflügers Archiv : European journal of physiology·Paola ImbriciMauro Pessia
Jun 18, 2003·Seizure : the Journal of the British Epilepsy Association·Felipe Antonio De MarcosFernano Cendes
Oct 22, 2004·Human Molecular Genetics·Hsien-Yang LeeLouis J Ptácek
Oct 8, 2005·The Journal of Physiology·Simin KhavandgarKamran Khodakhah
Sep 8, 2006·American Journal of Physiology. Cell Physiology·Paola ImbriciMauro Pessia
Mar 31, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Sanjeev RajakulendranMichael G Hanna
Jun 19, 2007·Brain : a Journal of Neurology·J C JenUNKNOWN CINCH investigators
Oct 4, 2007·Muscle & Nerve·Steven J ShookLan Zhou
Oct 17, 2008·Physiological Reviews·Helene VacherJames S Trimmer
Jan 2, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Andrea Lorincz, Zoltan Nusser
Feb 11, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Michelle K DemosLinlea Armstrong

❮ Previous
Next ❯

Citations

Jun 1, 2016·Frontiers in Pharmacology·Paola ImbriciDiana Conte
Aug 2, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Enriqueta Tristán-ClavijoAmalia Martinez-Mir
Aug 28, 2016·Revue neurologique·A Méneret, E Roze
Sep 27, 2016·Journal of Movement Disorders·Kwang-Dong Choi, Jae-Hwan Choi
May 18, 2018·Current Opinion in Neurology·Eavan M McGovernTimothy J Counihan
May 24, 2018·Nephron·Jenny van der WijstJeroen H F de Baaij
Feb 22, 2017·Scientific Reports·Elizabeth A Ferrick-KiddieRonald B Emeson
Dec 22, 2017·Pharmacological Reviews·Julia OyrerChristopher A Reid
Oct 7, 2019·Journal of Medical Genetics·Edgard VerduraAurora Pujol
Jun 24, 2017·Neurology. Neuroimmunology and Neuroinflammation·Bastien JoubertJérôme Honnorat
Mar 29, 2020·The Journal of Pharmacology and Experimental Therapeutics·Rían W Manville, Geoffrey W Abbott
Apr 1, 2020·Cardiovascular Research·Lia CrottiMichael C Sanguinetti
May 24, 2020·International Journal of Molecular Sciences·Giacomo GaroneFrancesco Nicita
May 13, 2020·Pflügers Archiv : European journal of physiology·Paola ImbriciMaria Cristina D'Adamo
Sep 10, 2020·International Journal of Molecular Sciences·Paola GiuntiMarina Frontali
Aug 25, 2018·Frontiers in Neurology·Zeynep S KaralokMaria C D'Adamo
Apr 23, 2020·International Journal of Molecular Sciences·Kelsey PaulhusEdward Glasscock
Apr 26, 2020·International Journal of Molecular Sciences·Maria Cristina D'AdamoPaola Imbrici
May 7, 2020·Movement Disorders Clinical Practice·Simone Gana, Enza Maria Valente

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.